x
|
Quarterly
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
|
|
For
the quarterly period ended March
31, 2008
|
|
|
o
|
Transition
report under Section 13 or 15(d) of the Exchange Act
|
|
|
|
For
the transition period from _____________ to
_____________
|
Delaware
|
02-0762508
|
|
(State
or other Jurisdiction of Incorporation or
Organization)
|
(I.R.S.
Employer Identification No.)
|
14
Hamelacha Street Park Afek, Rosh Ha'ayin 48091,
Israel
|
(Address
of Principal Executive Office)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
(Do not check if a smaller reporting company).
|
Smaller
reporting company x
|
|
|
Page
|
Part
I. Financial Information:
|
|
|
|
|
|
|
Item
1 - Financial Statements (Unaudited):
|
|
|
|
|
|
Condensed
Balance Sheets as of March 31, 2008 and December 31, 2007
|
2
|
|
|
|
|
Condensed
Statements of Operations for the Three Months Ended March 31, 2008,
the
three Months Ended March 31, 2007, and the Period December 27, 2005
(inception) to March 31, 2008
|
3
|
|
|
|
|
Condensed
Statements of Stockholders’ Equity for the Period December 27, 2005
(inception) to March 31, 2008
|
4
|
|
|
|
|
Condensed
Statements of Cash Flows for the three Months Ended March 31, 2008,
the
Three Months Ended March 31, 2007, and the Period December 27, 2005
(inception) to March 31, 2008
|
5
|
|
|
|
|
Notes
to Unaudited Condensed
Financial Statements
|
6
|
|
|
|
|
Item
2 - Management’s Discussion and Analysis of Financial Condition and
Results of Operations
|
11
|
|
|
|
Item
3 - Quantatitive and Qualitative Disclosures About Market
Risk
|
12
|
|
|
Item 4
- Controls and Procedures
|
12
|
|
|
|
Part
II. Other Information
|
|
|
|
|
|
Item 1
- Legal Proceedings
|
13
|
|
Item 1A
- Risk Factors
|
13
|
|
|
Item
2 - Unregistered Sales of Equity Securities and Use of
Proceeds
|
13
|
|
|
|
|
Item
6 - Exhibits
|
13
|
|
|
|
|
Signatures
|
14
|
March
31,
|
|
December
31,
|
|
||||
2008
|
|
2007
|
|||||
|
(Unaudited)
|
||||||
ASSETS
|
|||||||
CURRENT
ASSETS:
|
|||||||
Cash
|
$
|
8,179
|
$
|
35,238
|
|||
Investments
held in Trust (Note 3)
|
27,755,811
|
27,575,303
|
|||||
Prepaid
expenses
|
3,641
|
1,456
|
|||||
Deferred
tax asset
|
165,136
|
165,136
|
|||||
Income
tax receivable (Note
6)
|
17,844
|
17,844
|
|||||
Total
assets
|
$
|
27,950,611
|
$
|
27,794,977
|
|||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
642,281
|
$
|
369,181
|
|||
Deferred
trust interest income
|
299,483
|
263,399
|
|||||
Deferred
underwriting fee (Note
2)
|
352,350
|
352,350
|
|||||
Total
current liabilities
|
1,294,114
|
984,930
|
|||||
Common
stock , subject to possible conversion,
906,547
shares at conversion value
|
5,248,907
|
5,248,907
|
|||||
STOCKHOLDERS'
EQUITY
|
|||||||
Preferred
stock - $.0001 par value; 1,000,000 authorized; none issued or outstanding
(Note 5)
|
-
|
-
|
|||||
Common
stock - $.0001 par value; 21,000,000 authorized; 5,868,334 issued
and
outstanding (including 906,547 subject to possible conversion) (Note
1)
|
587
|
587
|
|||||
Additional
paid-in capital
|
21,409,192
|
21,409,192
|
|||||
Retained
earnings (accumulated deficit) accumulated during the development
stage
|
(2,189
|
)
|
151,361
|
||||
Total
stockholders' equity
|
21,407,590
|
21,561,140
|
|||||
Total
liabilities and stockholders' equity
|
$
|
27,950,611
|
$
|
27,794,977
|
Three
months ended
March
31,
|
Three
months ended
March
31,
|
|
For
the period from December 27, 2005 (inception) to March
31,
|
|||||||
|
|
2008
|
2007
|
2008
|
|
|||||
Interest
income
|
$
|
144,424
|
$
|
261,647
|
$
|
1,209,083
|
||||
General
and administrative expenses
|
||||||||||
State
franchise tax
|
$
|
6,381
|
$
|
6,438
|
$
|
57,656
|
||||
Admin
and office support
|
22,500
|
22,500
|
132,526
|
|||||||
Professional
fees
|
225,479
|
7,313
|
824,801
|
|||||||
Insurance
|
10,922
|
11,250
|
63,204
|
|||||||
Travel
|
16,782
|
9,003
|
86,001
|
|||||||
Formation
expenses
|
-
|
-
|
3,000
|
|||||||
Other
expenses
|
15,910
|
8,423
|
44,085
|
|||||||
Total
costs and expenses
|
297,974
|
$
|
64,927
|
1,211,273
|
||||||
Income
(loss) before provision for income taxes
|
(153,550
|
)
|
196,720
|
(2,190
|
)
|
|||||
Provision
for (benefit from) income taxes
|
-
|
66,885
|
(1
|
)
|
||||||
Net
income (loss) for the period
|
(153,550
|
)
|
$
|
129,835
|
(2,189
|
)
|
||||
Weighted
average number of shares outstanding, basic and diluted
|
5,868,334
|
5,868,334
|
4,159,764
|
|||||||
Net
income (loss) per share
|
$
|
(0.03
|
)
|
$
|
0.02
|
$
|
(0.00
|
)
|
Common
Stock
|
Additional
paid
in
|
Retained
Earnings
(Deficit)
Accumulated
during
the
development
|
||||||||||||||
Shares
|
Amount
|
capital
|
stage
|
Total
|
||||||||||||
Issuance
of Common Stock to initial stockholders on December 30, 2005 at $.025
per
share
|
1,000,000
|
$
|
100
|
$
|
24,900
|
$
|
-
|
$
|
25,000
|
|||||||
Net
loss for the period
|
-
|
-
|
-
|
(3,000
|
)
|
(3,000
|
)
|
|||||||||
Balance
as of December 31, 2005
|
1,000,000
|
$
|
100
|
$
|
24,900
|
$
|
(3,000
|
)
|
$
|
22,000
|
||||||
Sale
of 4,535,000 Units (net of $2,576,418 offering expenses, including
the
issuance of 906,547 shares subject to possible conversion)
|
4,535,000
|
454
|
24,633,128
|
-
|
24,633,582
|
|||||||||||
Gross
proceeds from issuance of Unit Purchase Option
|
-
|
-
|
100
|
-
|
100
|
|||||||||||
Gross
proceeds from Issuance of Insider Units
|
333,334
|
33
|
1,999,971
|
-
|
2,000,004
|
|||||||||||
Proceeds
subject to possible conversion
|
-
|
-
|
(5,248,907
|
)
|
-
|
(5,248,907
|
)
|
|||||||||
Net
income for the year
|
-
|
-
|
-
|
89,329
|
89,329
|
|||||||||||
Balance
as at December 31, 2006
|
5,868,334
|
$
|
587
|
$
|
21,409,192
|
$
|
86,329
|
$
|
21,496,108
|
|||||||
Net
income for the year
|
-
|
-
|
-
|
65,032
|
65,032
|
|||||||||||
Balance
as at December 31, 2007
|
5,868,334
|
$
|
587
|
$
|
21,409,192
|
$
|
151,361
|
$
|
21,561,140
|
|||||||
Unaudited:
|
||||||||||||||||
Net
loss for the period
|
-
|
-
|
-
|
(153,550
|
)
|
(153,550
|
)
|
|||||||||
Balance
as at March 31, 2008
|
5,868,334
|
$
|
587
|
$
|
21,409,192
|
$
|
(2,189
|
)
|
$
|
21,407,590
|
Three
months
ended
March
31,
|
Three
months
ended
March
31,
|
For
the period from December 27, 2005 (inception)
to
March 31,
|
|
|||||||
2008
|
|
2007
|
|
2008
|
||||||
|
||||||||||
Cash
flows from operating activities:
|
||||||||||
Net
income (loss)
|
$
|
(153,550
|
)
|
$
|
129,835
|
$
|
(2,189
|
)
|
||
Adjustments
to reconcile net income (loss) to net cash used in operating
activities:
|
||||||||||
Interest
earned on securities held in trust
|
(180,508
|
)
|
(322,495
|
)
|
(1,498,161
|
)
|
||||
Changes
in operating assets/liabilities:
|
||||||||||
Decrease
(increase) in pre-paid expenses
|
(2,185
|
)
|
(9,125
|
)
|
(3,641
|
)
|
||||
Increase
(decrease) in accrued expenses
|
273,100
|
20,452
|
642,281
|
|||||||
Increase
in deferred tax asset
|
-
|
(41,805
|
)
|
(165,136
|
)
|
|||||
Increase
in deferred trust interest income
|
36,084
|
64,467
|
299,483
|
|||||||
Increase
(decrease) in income tax payable
|
-
|
18,689
|
(17,844
|
)
|
||||||
Net
cash used in operating activities
|
(27,059
|
)
|
(139,982
|
)
|
(745,207
|
)
|
||||
Cash
flows from investing activities:
|
||||||||||
Cash
held in trust fund
|
-
|
-
|
(26,257,650
|
)
|
||||||
Redemption
of Treasury Bill held in trust
|
-
|
26,563,000
|
(26,870,000
|
)
|
||||||
Purchase
of Treasury Bill held in trust
|
-
|
(26,563,000
|
)
|
54,433,000
|
||||||
Purchase
of Money Fund held in trust
|
-
|
-
|
(26,563,000
|
)
|
||||||
Net
cash (used in) investing activities
|
-
|
-
|
(26,257,650
|
)
|
||||||
Cash
flows from financing activities:
|
||||||||||
Payment
of notes payable - stockholders
|
-
|
-
|
(115,000
|
)
|
||||||
Proceeds
from sale of Units to public
|
-
|
-
|
27,210,000
|
|||||||
Proceeds
from issuance of shares to Initial Stockholders
|
-
|
-
|
25,000
|
|||||||
Proceeds
from notes payable - stockholders
|
-
|
-
|
115,000
|
|||||||
Proceeds
from sale of Unit Purchase Option
|
-
|
-
|
100
|
|||||||
Proceeds
from sale of Insider Units
|
-
|
-
|
2,000,004
|
|||||||
Payment
of offering expenses
|
-
|
-
|
(2,224,068
|
)
|
||||||
Net
cash provided by financing activities
|
-
|
-
|
27,011,036
|
|||||||
Increase
(decrease) in cash
|
(27,059
|
)
|
(139,982
|
)
|
8,179
|
|||||
Cash
at the beginning of the period
|
35,238
|
692,100
|
-
|
|||||||
|
||||||||||
Cash
at the end of the period
|
$
|
8,179
|
$
|
552,118
|
$
|
8,179
|
||||
|
||||||||||
Supplemental
Schedule of non-cash investing financing activities :
|
||||||||||
Deferred
Underwriting Fee
|
$
|
-
|
$
|
-
|
$
|
352,350
|
||||
Accrued
offering costs
|
$
|
-
|
$
|
-
|
$
|
-
|
a. |
On
April 28, 2008, Fortissimo Capital Fund GP, L.P., one of the
initial
stockholders of the Company, provided an interest-free loan to
the Company
in the amount of $100,000. Such loan is due upon the earlier
of (i)
October 11, 2008 or (ii) consummation of a business combination
with an
operating company.
|
b. |
On
May 12, 2008, the Company and Psyop entered into an amendment to
the
Merger Agreement between the parties dated January 15, 2008. The
amended
terms reflect primarily changes to the consideration payable to
Psyop. The
initial cash payment is reduced from $10,140,179 to $4,140,179.
A payment
of up to $6 million in cash is payable in 2008 and 2009 ($3 million
in
each year), in the event that the at least 90% of the EBITDA milestones
in
each of those years is attained (payable on a sliding scale). The
prior
revenue and EBITDA targets for 2008, 2009 and 2010 remain the same,
the
only change is that the payment is adjusted in the event that 85%
to 125%
(90% for revenue target in 2008) are achieved, whereas, previously
the
earn-out was payable in the event that 70% of the target was
achieved.
|
(a) |
Exhibits:
|
|||
31.1 - |
Certification
by Chief Executive Officer pursuant to Exchange Act
Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|||
31.2 - |
Certification
by Chief Financial Officer pursuant to Exchange Act
Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|||
32.1 - |
Certification
by Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act
of 2002
|
|||
32.2 - |
Certification
by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
FORTISSIMO
ACQUISITION CORP.
|
||
|
|
|
Dated:
May 15,
2008
|
By: |
/s/ Yuval
Cohen
|
Yuval
Cohen
|
||
Chairman
of the Board and Chief Executive
Officer
|
By: |
/s/ Eli
Blatt
|
|
Eli
Blatt
|
||
Chief
Financial Officer
|